false
0001607962
00-0000000
0001607962
2026-10-04
2026-10-04
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported):
October 4, 2026
Lifeward
Ltd.
(Exact name of registrant as specified in its charter)
| Israel |
|
001-36612 |
|
Not applicable |
|
(State or other jurisdiction of
incorporation or organization) |
|
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
| 2 Cabot Rd., Hudson, MA |
|
01749 |
| (Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: +508.251.1154
Not Applicable
(Former name or former address, if changed since
last report)
Securities registered pursuant to
Section 12(b) of the Exchange Act |
|
Trading Symbol |
|
Name of each exchange
on which
registered
|
| Ordinary Shares, no par value |
|
LFWD |
|
Nasdaq Capital Market |
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 5.02 |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
As previously reported in Current Reports on
Form 8-K filed with the Securities and Exchange Commission on August 31, 2026 and October 1, 2026, Lifeward Ltd. (the “Company”)
appointed Rami Aviram as its Chief Financial Officer, principal financial officer and principal accounting officer, effective November
1, 2026. On October 4, 2026, Mr. Aviram informed the Company that he has decided not to join the Company and, accordingly, will not assume
the role of Chief Financial Officer.
As disclosed in the October 1, 2026 Form 8-K,
Josh Hexter currently serves as the Company’s interim principal financial officer and principal accounting officer. Mr. Hexter will
continue to serve in these capacities until a successor is appointed. Mr. Hexter will not receive any additional compensation in connection
with his continued service in these capacities.
The Company is conducting a search to identify a
permanent successor for the Chief Financial Officer position and will announce a successor at the conclusion of the ongoing search process.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
Lifeward Ltd. |
| |
|
|
| Dated: October 8, 2026 |
By: |
/s/ Josh Hexter |
| |
Name: |
Josh Hexter |
| |
Title: |
Interim Chief Executive Officer |
